MCK
Healthcare · Medical Distribution
Performance
MCK (MCK) Stock Analysis 2026
Rule-based · Updated daily · Not financial advice
MCK (MCK) operates in the Medical Distribution space within the Healthcare sector. With a market cap of $92.0B, it qualifies as a mid-cap company. Growth is moderate and the business remains profitable, offering a balanced risk/reward profile compared to high-multiple peers.
- Forward P/E (15.6×) is lower than trailing P/E (20.5×) — analysts expect earnings to improve
- Revenue growth of 6% YoY shows solid business momentum
- Earnings grew 37% YoY — bottom-line is expanding fast
- Low beta of 0.32 — less volatile than the market, suitable for conservative portfolios
- Thin profit margin of 1.2% — little buffer against cost increases
- Current ratio below 1 (0.85×) — short-term liabilities exceed current assets
Verdict
Buy / Hold
More positives than negatives. Fundamentals support holding while monitoring key risks.
AI Insight
Powered by ClaudeAI-generated analysis for informational purposes only. Not financial advice.
Related Articles
Revenue & Results
Dividends
Current DY
0.42%
5Y Avg Annual
$2.3400
Last Payment
$0.8200
Ex-Date
06/01/2026
Annual dividends paid per share
| Ex-Date | Payment | Amount | Est. DY |
|---|---|---|---|
Latest06/01/2026 | 07/01/2026 | $0.8200 | 0.42% |
03/02/2026 | 04/01/2026 | $0.8200 | 0.42% |
12/01/2025 | 12/31/2025 | $0.8200 | 0.42% |
09/02/2025 | 10/02/2025 | $0.8200 | 0.42% |
06/02/2025 | 07/02/2025 | $0.7100 | 0.36% |
03/03/2025 | 04/02/2025 | $0.7100 | 0.36% |
12/02/2024 | 01/01/2025 | $0.7100 | 0.36% |
08/30/2024 | 09/29/2024 | $0.7100 | 0.36% |
Magic Number
Shares needed to self-fund your next purchase
$785.44
Price
$0.8200
Last div. (quarterly)
958
shares
Own 958 MCK shares ($752,451.52) and each quarterly dividend pays for 1 new share — the snowball runs on its own.
Investment target
$752,451.52
New shares / year
+4 shares
If You Had Invested…
Hypothetical return based on historical prices
* Dividend reinvestment calculated at ex-date price. For informational purposes only.
Earnings
Next Earnings
Aug 5, 2026
50
days
EPS (TTM)
$38.37
P/E (TTM)
20.5
Fwd P/E
15.6
Earnings History
SEC EDGAR · official filings
SEC Filings
Official EDGAR documents
Key Statistics
Valuation
Trading
Dividends
Profitability
Balance Sheet
Fair Value Estimates
Current price: $785.44
Graham Number
√(22.5 × EPS × Book Value)
N/A
Benjamin Graham's intrinsic value formula. Assumes a fair stock trades at no more than 22.5× the product of EPS and book value per share.
Bazin Ceiling Price
Avg. Annual DPS (5Y) ÷ 6%
$39.47
Décio Bazin's dividend-based ceiling. The max price you should pay so that dividends alone deliver at least 6% annual yield on your cost basis.
These are simplified estimates. Not financial advice.
Buy & Hold Checklist
Quality criteria for long-term holding
7/10
88% score
Pays dividends
15Y hist.15+ years of dividend history
Dividend consistency (5Y+)
15 yrsUninterrupted dividend payments for at least 5 years
ROE above 10%
Return on equity — measures how efficiently capital is used
Positive profit margin
1.2%Net profit margin must be positive — company earns more than it spends
Revenue growth (annual)
+6.0%Annual revenue must be growing compared to the prior year
Earnings growth (annual)
+37.2%Annual earnings must be growing compared to the prior year
Debt/Equity below 2×
Low financial leverage reduces risk of distress
Current ratio above 1
0.85×Short-term assets must cover short-term liabilities
Daily liquidity above $5M
$807M/dayHigh trading volume ensures easy entry and exit
Dividend yield above 0%
0.42%Stock must distribute income to shareholders
Related Assets
Healthcare
About MCK
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Sector
Healthcare
Industry
Medical Distribution
Location
Irving, United States
Employees
41,600